Easily Navigate Using Visualizations

A key component of Location Feasibility is visualizations, which are innovative interfaces that enable easy navigation of feasibility analytics from country to postal code level, worldwide.

Visualizations are powerful not only for navigation, but also for interpretation.

These intuitive visual interfaces allow trial planners to easily uncover insights from the hundreds of millions of feasibility data points integrated within the ViS platform. And because visualizations are multi-dimensional and interactive, trial planners have access to the feasibility analytics that they need when they need them.

ViS' patent-pending visualizations allow trial planners to master all stages of the location feasibility process. From understanding the global disease-specific landscape to selecting the best research centers in a location, visualizations provide trial planners with a location feasibility edge.

Customize Using Filters and Dimensions

The ViS output is dynamically generated for each trial planner's unique needs using user-specified inputs, which include filters and dimensions.

Trial planners can set two primary filters:

Disease - Includes 67 diseases and a pediatric only optionLocation - From country to city level, worldwide

These filters are used in combination with over 20 dimensions.

The various dimensions can be quickly toggled through, while preserving disease and location filters, to quickly get a multi-dimensional view of the feasibility landscape.

ViS' 20+ dimensions are contained within 4 major analytics types:

Patient Population

Enrolled Patients

Available Patients

Available Patients per Trials at Site Level

Available Patients per Centers

Engagement Level

Available Patients and Patient Engagement Level

Enrolled Patients

Description
Number of patients enrolled in a clinical trial, measured within particular location parameters.

Use Case
Determine locations with high or low patient participation in trials. For considerable enrollment gains, find high enrolling research centers in high participation locations.

Available Patients

Description
Number of patients available to enroll in a clinical trial, measured within particular disease and location parameters.

Use Case
Determine locations where the desired patient population is most concentrated, while identifying research centers within those locations.

Available Patients Per Trials at Site Level

Description
Number of patients available to enroll in a clinical trial in proportion to the number of active clinical trials, measured within particular disease and location parameters.

Use Case
Determine locations with a high concentration of available patients and low concentration of active clinical trials, while identifying research centers within those locations.

Available Patients Per Centers

Description
Number of patients available to enroll in a clinical trial in proportion to the number of clinical trial research centers, measured within particular disease and location parameters.

Use Case
Determine locations in which research centers have low local competition for a large pool of available patients, while identifying research centers within those locations.

Engagement Level

Description
Number of patients available to enroll in a clinical trial in proportion to the number of patients enrolled in a clinical trial, measured within user-specified disease and location parameters.

Use Case
Determine locations in which patients are highly engaged in clinical trials, while identifying research centers within those locations.

Available Patients and Patient Engagement Level

Description
Concurrent view of both Available Patients and Patient Engagement Level analytics.

Use Case
Determine locations that have both a large pool of available patients who are highly engaged in clinical trials, while identifying research centers within those locations.

All Trials

Description
Number of trials in all phases initiated in the last 5 years across all research centers, measured within particular disease and location parameters.

Use Case
Determine locations where clinical trials for a particular disease have been most concentrated during the last 5 years.

Phase I Trials

Description
Number of Phase I trials initiated in the last 5 years across all research centers, measured within particular disease and location parameters.

Use Case
Determine locations where Phase I clinical trials for a particular disease have been most concentrated during the last 5 years.

Phase II Trials

Description
Number of Phase II trials initiated in the last 5 years across all research centers, measured within particular disease and location parameters.

Use Case
Determine locations where Phase II clinical trials for a particular disease have been most concentrated during the last 5 years.

Phase III Trials

Description
Number of Phase III trials initiated in the last 5 years across all research centers, measured within particular disease and location parameters.

Use Case
Determine locations where Phase III clinical trials for a particular disease have been most concentrated during the last 5 years.

Phase IV Trials

Description
Number of Phase IV trials initiated in the last 5 years across all research centers, measured within particular disease and location parameters.

Use Case
Determine locations where Phase IV clinical trials for a particular disease have been most concentrated during the last 5 years.

Ongoing Trials

Description
Number of currently active trials in all phases across all research centers, measured within particular disease and location parameters.

Use Case
Determine locations where clinical trials for a particular disease are currently active.

All Trials and Growth Rate

Description
Concurrent view of both All Trials and Growth Rate. Growth rate is based on weighted year-to-year changes in share of overall research activity compared to others, measured within particular location parameters.

Use Case
Determine locations with an industry increase or decrease in preference during the last 5 years.

Research Activity

All Trials

Phase I Trials

Phase II Trials

Phase III Trials

Phase IV Trials

Ongoing Trials

All Trials and Growth Rate

Research Infrastructure

Centers

Centers and Trials per Center

Preference Level

Centers

Description
Number of research centers, measured within user-specified location parameters.

Use Case
Determine locations with a high or low concentration of research centers. For example, high concentration may indicate advanced research infrastructure but limited capacity for new trials.

Centers and Trials per Center

Description
Concurrent view of both Centers and Trials per Center. Trials per center is the average number of trials hosted per center during the last 5 years, as measured within user-specified location parameters.

Use Case
Determine locations with a high concentration of research centers and low concentration of trials per center to identify underutilized research capacity.

Preference Level

Description
Percentage of trials in the last 5 years where this location is selected, as measured within user-specified disease and location parameters.

Use Case
Determine locations that are most or least popular with trial planners during the last 5 years. Commonly chosen locations tend to indicate desirable qualities identified by trial planners.

Investigators

Description
Number of investigators, measured within user-specified disease and location parameters.

Use Case
Identify extra capacity of qualified investigators who are actively engaged in clinical trials for a specified disease of interest.

Research Personnel

Investigators

Uncover and Understand Ideal Locations Using Location Profiles

Location Profiles are dynamically updated pages consolidating all of the disease-specific analytics for each country, state, and city, worldwide.